GOODWILL(688246)2025-04-30 12:30Financial Performance - The company's operating revenue for the third quarter was ¥175,272,087.55, a decrease of 28.68% compared to the same period last year[4]. - The net profit attributable to shareholders was -¥13,787,288.80, representing a decline of 133.47% year-over-year[4]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥13,248,115.02, down 132.78% from the previous year[4]. - The net profit attributable to shareholders for the year-to-date period was -¥41,259,537.59, a significant decrease of 328.81% compared to the same period last year[4]. - The company reported a net loss of CNY 72,563,428.01 for the first three quarters of 2024, compared to a loss of CNY 19,149,698.80 in the same period of 2023[21]. - The total profit (loss) for the period was -73,586,781.02 RMB, compared to -19,188,968.02 RMB in the previous period[22]. - The net profit attributable to the parent company's shareholders was -41,259,537.59 RMB, down from 18,032,060.98 RMB year-over-year[23]. - The basic and diluted earnings per share for the third quarter were both -¥0.10, reflecting a decline of 133.33% year-over-year[5]. - The basic and diluted earnings per share were both -0.30 RMB, compared to 0.13 RMB in the same period last year[23]. Research and Development - Research and development expenses totaled ¥56,676,943.62, accounting for 32.34% of operating revenue, an increase of 9.06 percentage points year-over-year[5]. - Research and development expenses for the first three quarters of 2024 amounted to CNY 116,607,510.81, compared to CNY 127,290,711.34 in 2023, indicating a decrease of 8.3%[21]. Assets and Liabilities - Total assets at the end of the reporting period were ¥2,659,989,627.58, a slight increase of 0.54% from the end of the previous year[5]. - Total assets as of September 30, 2024, were CNY 2,659,989,627.58, slightly up from CNY 2,645,633,863.79 at the end of 2023[17]. - Total liabilities increased to CNY 889,967,888.54 as of September 30, 2024, compared to CNY 817,330,281.60 at the end of 2023, marking an increase of 8.8%[17]. - The company's equity attributable to shareholders decreased to CNY 1,773,506,823.62 as of September 30, 2024, down from CNY 1,821,580,993.57 at the end of 2023, a decline of 2.6%[17]. Cash Flow - The company reported a cash flow from operating activities of -¥162,335,536.26 for the year-to-date period[4]. - Cash flow from operating activities generated a net outflow of -162,335,536.26 RMB, an improvement from -226,519,885.58 RMB in the previous year[24]. - Cash inflow from investment activities was 30,477,529.64 RMB, significantly lower than 110,636,068.16 RMB in the prior year[25]. - Cash flow from financing activities resulted in a net inflow of 65,093,607.61 RMB, compared to a net outflow of -54,693,186.32 RMB last year[25]. - The total cash and cash equivalents at the end of the period were 303,496,223.85 RMB, down from 382,650,059.49 RMB at the end of the previous year[25]. - Cash and cash equivalents decreased to CNY 328,568,394.05 as of September 30, 2024, down from CNY 612,478,452.28 at the end of 2023, representing a decline of 46.3%[16]. - The company received 12,878,824.78 RMB in tax refunds, an increase from 8,746,067.31 RMB in the previous year[24]. - The company reported a decrease in cash received from sales of goods and services, totaling 366,295,717.03 RMB, compared to 371,112,264.71 RMB in the same period last year[24]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 5,576[11]. - The largest shareholder, Xia Jun, holds 24,750,839 shares, representing 17.99% of total shares[11]. - The second largest shareholder, Guoshou Chengda (Shanghai) Health Industry Equity Investment Center, holds 16,812,069 shares, representing 12.22%[11]. - The third largest shareholder, Hongyun Jiukang Data Technology (Beijing) Co., Ltd., holds 11,650,207 shares, representing 8.47%[11]. - The top 10 shareholders collectively hold significant stakes, with the largest three shareholders accounting for 38.68% of total shares[11]. - The company has a total of 4,604,868 shares held by Suzhou Saifu Puxin Medical Health Industry Investment Center, representing 3.35%[12]. - The total number of shares held by the top 10 unrestricted shareholders is 42,000,000 shares[12]. - The company has engaged in margin trading, with specific shares held through this method, including 1,765,000 shares by Beijing Haoqing Wealth Investment Management Co., Ltd.[13]. - The company has not reported any significant changes in shareholder structure due to margin trading activities[14]. Operational Status - There are no other important reminders regarding the company's operational status during the reporting period[14]. - The company did not execute any mergers or acquisitions during the reporting period[26].